Contrast Agents and Radiopharmaceuticals 2017

Similar documents
NUCLEAR MEDICINE APC TASK FORCE

RADIOPHARMACEUTICALS AND DRUGS ELIGIBLE FOR CONTINUED SEPARATE MEDICARE PAYMENT ( 2 TO 3 Year Transitional Period )

Official Listing of Radioactive Materials Approved for the Four Groups of Diagnostic Uses as Defined in 15A NCAC

Deleted Effective Beginning of Calendar Year Not Paid under Outpatient PPS Not Paid Under OPPS or any other Medicare payment system

Not Paid under Outpatient PPS. Deleted Effective Beginning of Calendar Year Not Paid under Outpatient PPS

SUGGESTED PRESCRIBED DOSAGE LIST

Prior Authorization for Non-emergency Cardiac Imaging Procedures

HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST

HIP RADIOLOGY PROGRAM CODE LISTS

Recent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department

Updated version

Click here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017.

2010 Radiology Prior Authorization List for UnitedHealthcare s HealthChoice Members

Water Any Inulin IV Normal renal function Inulin IV Abnormal renal function Glucose IV Normal Carfentanil IV 17.

Description MRI, TMJ C T Head Without Contrast C T Head With Contrast C T Head Without & With Contrast

Updated January 6, 2015

Updated July 3, 2014

Click here for Link to References: CMS Website HOPPS CY 2014 Final Rule (Fed. Reg. Version add B) Updated November 27, 2013

Paid under OPPS; separate APC payment. Separate cost-based pass-through payment; not subject to copayment. Paid under OPPS; separate APC payment

NUCLEAR MEDICINE IN VIVO

2017 St. Luke's-Roosevelt Nuclear Medicine Department Procedure Catalog. meds

Components of Preparedness

Department of Nuclear Medicine with Positron Emission Tomography

Last Updated: 2/10/2017 Implementation date: 4/3/2017 Radiology & Cardiology Prior Authorization / Utilization Management Procedure List

Procedure Guidelines. Nuclear Medicine

Nuclear Cardiology Reimbursement. Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN

Updated July 6, 2012 CMS ADDENDUM D1. Final OPPS Payment Status Indicators for CY Not paid under OPPS or any other Medicare Payment System.

FDA-approved radiopharmaceuticals

Radiopharmaceutical Activities Administered for Diagnostic and Therapeutic Procedures in Nuclear Medicine in Argentine: Results of a National Survey

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes

Anthem Blue Cross and Blue Shield Virginia Advanced Imaging Procedures Requiring Precertification Revised 02/13/2013

NUCLEAR MEDICINE APC TASK FORCE

RadTool Nuclear Medicine Flash Facts

Nuclear Medicine in Australia. Shaun Jenkinson

Sacred Heart Hospital on the Emerald Coast

POSITRON EMISSION TOMOGRAPHY (PET)

RADIOLOGY PROGRAM TABLE OF CONTENTS. OVERVIEW. . Assessment... and... Certification

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

Nuclear medicine studies of the digestiv system. Zámbó Katalin Department of Nuclear Medicine

Gastrointestinal tract

E LT O N A. M O S M A N OUTLINE

Radionuclide & Radiopharmaceuticals

Fidelis Care: Cardiology, Radiology, and Ultrasound CPT Code List

Radiopharmacy. Prof. Dr. Çetin ÖNSEL. CTF Nükleer Tıp Anabilim Dalı

Radiopharmaceutical: Cr-51 RBCs, µci Useful in evaluating patients with anemia of unknown etiology when a hemolytic process is suspected

Health Concerns Related to Radiation Exposure. of the Female Nuclear Medicine Patient. Michael G. Stabin

Contributions of Nuclear Isotopes in Medicine, a Perspective

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

General Nuclear Medicine

weighing risks against benefits ALARA principle appropriate activities (radiopharmaceutical doses)

Radionuclides in Medical Imaging. Danielle Wilson

Release of Patients or Human Research Subjects Administered Radioactive Materials

Dr Alfred O Ankrah FCNP

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE

Itroduction to the Nuclear Medicine: biophysics and basic principles. Zámbó Katalin Department of Nuclear Medicine

PHARMACEUTICALS IN MEDICAL IMAGING

Cardiac Imaging Tests

Steven G. Marsh MS, DABMP, Medical Health Physics RSO - Baystate Health Springfield, MA

Special Imaging MUSCULOSKELETAL INFECTION. Special Imaging. Special Imaging. 18yr old male pt What is it? Additional Imaging

Basics of nuclear medicine

AN INTRODUCTION TO NUCLEAR MEDICINE

Page 1 HORIZON NJ HEALTH PRE-AUTHORIZATION CODES MANAGED BY NIA HORIZON NJ HEALTH 7/22/14 CODE CODE PROCEDURE PROCEDURE

SCINTIGRAPHY OF THE CENTRAL NERVOUS SYSTEM Part 1: Introduction and BBB studies

Clinical indications for positron emission tomography

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Excretion Factors: the percentage of administered radioactivity released to sewer for routinely used radiopharmaceuticals.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

PRODUCT CATALOGUE. A complete palette in Nuclear Medicine. Oncology. Cardiology. Neurology

Cigna - Prior Authorization Procedure List: Radiology & Cardiology

Nuclear Medicine in Oncology

Outline. Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) SPECT/CT and PET/CT Dosimetry

Annex III. Amendments to relevant sections of the product information

NUCLEAR CARDIOLOGY UPDATE

Radioisotopes in Nuclear Medicine

Section XII Nuclear Radiology

A Doctor's Guide to Nuclear Medicine

Indium-111 Zevalin Imaging

BlueAdvantage SM. & BlueChoice SM Radiology Prior Authorization Program Code List CPT /HCPS

Renal. Prof John Buscombe

F NaF PET/CT in the Evaluation of Skeletal Malignancy

Cigna - Prior Authorization Procedure List: Radiology & Cardiology

Nuclear Medicine Diagnosis

Nuclear medicine studies of the digestiv system. Zámbó Katalin Department of Nuclear Medicine

Radiation Dosimetry for CT Protocols

73725x2 MRA Pelvis Runoff (to ankle) CTA Abdomen with & without CTA Cardiac Brain without 70551

Nuclear medicine in oncology. 1. Diagnosis 2. Therapy

Nuclear Medicine Technique I

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Nuclear Medicine in the Diabetic Foot

Isotopes in Functional Cancer Imaging

INFECTION & INFLAMMATION IMAGING

Index. radiologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

PHYSICAL CHARACTERISTICS

Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs)

ITEM WRITERS' GUIDELINES. for the PET SPECIALTY EXAM. offered by the NUCLEAR MEDICINE TECHNOLOGY CERTIFICATION BOARD

CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82

Thyroid Cancer. With 51 Figures and 30 Tables. Springer

spect lab Shoot for the Moon. Even if you miss, you ll land among the stars. nuclear medicine services Visit us at :

Transcription:

Contrast Agents and Radiopharmaceuticals 207 Covered: Code Code Description Allow with Code(s) Code Description Max Units A464 Radiopharmaceutical, diagnostic, not otherwise classified n/a Invoice Req'd A9500 A9502 A9503 A9505 A9507 A9508 Technetium Tc-99m, Sestamibi, diagnostic, per study dose Technetium Tc-99m tetrofosmin, diagnostic, per study dose Technetium Tc-99m, Medronate, (MDP), diagnostic, per study dose, up to 30 mci's Thallous Chloride TL-20, diagnostic, per mci Indium IN Capromab Pendetide (ProstaScintâ) per study dose, up to 0 mci's Iobenguane sulfate- Metaiodobenzyl guanidine (MIBG) 7845-78454 Myocardial perfusion studies 2 78070-78072 Parathyroid study 78605-78607, 78800- Tumor imaging 78804 7845-78454 Myocardial perfusion studies 2 78070-78803 Parathyroid study 78300-78320 Bone scan 7845-78454 Cardiac imaging 4 78070-78072 Parathyroid imaging 4 78800-78804 Tumor imaging 4 78607 Brain imaging 4 78800-78804 Tumor detection 78075 Adrenal imaging 78800-78804 Neuroblastoma imaging A9509 Iodine I-23 Sodium Iodide, diagnostic, per millicurie 7802-7808, 78020, 78070-78072 Thyroid imaging 5 A950 Technetium Tc-99m Disofenin (Hepatolite, DISIDA), per study dose, up to 5 mci's 78226, 78227 Hepatobiliary scan agent of 7

A952 A956 A9520 A952 Technetium Tc-99m- Pertechnetate, Diagnostic, per mci Iodine I-23 Sodium iodide capsule(s), Diagnostic per 00 Microcuries, up to 999 microcuries Technetium tc-99m, tilmanocept, diagnostic, up to 0.5 millicurie Technetium Tc-99m Exametazine (Ceretec ), Diagnostic, per study dose, up to 25 mci s 7802-7805 Thyroid study 78600-78607, 7860 Brain study 7848, 78483 First-pass cardiac technique studies 7826 Gastric mucosa imaging 78290 Intestine imaging 7829 Peeritoneal-Venous shunt study 78070-78072 Parathyroid study 78230-78232 Parotid or salivary scan 78730 Urinary bladder residual 78740 Ureteral reflux study 78630-78650 Cerebrospinal fluid flow, imaging 78660 Dacryocystography 7876 Testicular imaging with vascular flow 7802-7808, 78020, 78070-78072 Invoice Req'd Thyroid imaging 4 7895 Lynph Node Imaging 78600-78607, 7860 Brain perfusion 2 780-78, 7822 Plasma Volume 5 A9524 A9528 A9529 A953 Iodinated I-3-Serum Albumin, diagnostic, per 5 microcuries Iodine I-3 Sodium Iodide capsule(s), Diagnostic, per mci Iodine I-3 Sodium Iodide solution, Diagnostic, per mci Iodine I-3 Sodium Iodide, Diagnostic, per microcurie (up to 00 microcuries) 78600-78607, 7860 Brain imaging 5 78579-78598 Pulmonary perfusion imaging 5 7845-78454 Cardiac imaging 5 78800-78804 Tumor imaging 5 78472-78473, 7848- Cardiac Blood Pooling imaging 78483 5 7802-7808, 78803 Thyroid uptake and imaging 8 7802-7808, 78803 Thyroid uptake and imaging 8 7802-7808, 78803 Thyroid uptake and imaging 80 2 of 7

A9537 A9538 A9539 A9540 Technetium Tc-99m Mebrofenin (Choletec ) Diagnostic, per study dose, up to 5 mci's Technetium Tc-99m Pyrophosphate (PYP) (Pyrolite ) Technetium Tc-99m Pentetate, Diagnostic, per study dose, up to 25 mci's Technetium Tc-99m Macroaggregated Albumin (MAA), Diagnostic, per study dose, up to 0 mci s 78226, 78227 Hepatobiliary scan agent 78300-78320 Bone and/or joint imaging 78466-78469 Myocardial infarct imaging 78579-78598 Lung ventilation 7876 Testicular imaging with vascular flow 78700-78725 GFR renal scan 78730 Urinary bladder residual 78740 Ureteral reflux 78630-78650 CSF study 78600-78607, 7860 Brain study 7829, 78645 Shunt patency agent. 500 uci 7848, 78483 First-pass cardiac technique studies 78445 Vascular flow study 78428 Cardiac shunt detection 78579-78598 Lung perfusion agent 7829 Peritoneal-Venous Shunt Study 7826, 78428 Cardiac Shunt Detection 7820, 78205, 7825 Liver imaging 78800, 7880, 78803 Tumor imaging 7885 Spleen imaging 7802-7804 Bone marrow studies 7820-7826 Liver, spleen imaging 78730 Urinary bladder residual study A954 A9542 Technetium Tc-99m Sulfur Colloid, Diagnostic, per study dose, up to20 mci's Indium-IN- Ibritumomab Tiuxetan, Diagnostic, per study dose, up to 5 mci's 7895 Lymphatics & Lymph glands 78258, 78262 Gastroesophageal reflux studies Gastric emptying, gastric 78264, 78265, 78266 emptying with colonic transit studies 78278 GI bleed studies 7829 Peritoneal-pleural shunt studies 78470 Ureteral reflux study 78804 Radiopharmaceutical localization of tumor 3 of 7

A9547 A9548 A955 A9553 A9554 A9556 A9557 A9558 A9560 A956 A9562 Indium-IN- Oxyquinoline, Diagnostic, per 0.5 mci Indium IN- Pentetate (MyoScint ) Diagnostic, per 0.5 mci Technetium Tc-99m Succimer (DMSA), Diagnostic, per study dose, up to 0 mci's Chromium CR-5 Sodium Chromate, Diagnostic, per study dose, up to 250 microcuries Iodine-25 Sodium Iothalamate (Glofil-25 ), Diagnostic, per study dose, up to 0 microcuries Gallium Ga-67 Citrate, Diagnostic, per mci Technetium Tc-99m Bicisate (Neurolite ), Diagnostic, per study dose, up to 25 mci's Xenon Xe-33 Gas, Diagnostic, per 0 mci s Technetium Tc-99m Labeled Red Blood Cell's (RBC's) Diagnostic, per study dose, up to 30 mci s (Ultra Tag or cold pyrophosphate (pyp) +99m technetium) Technetium Tc-99m Oxidronate, Diagnostic, per study dose, up to 30 mci's Technetium Tc-99m Mertiatide (MAG-3), diagnostic, per study dose, up to 5 mci's 78805-78807, 7885 Leukocyte labeling 7890-789 Platelet labeling 78630, 78635,78645, 78647 Cerebrospinal fluid flow, imaging 78650 CSF leakage and detection 78800 Localization of tumor 78700-7870 Parenchymal renal scan 78800-78804 Tumor detection 7820-7822 RBC Mass 7830-7835, 7840 RBC Survival 7890-789 Platelet Survival 78707-78709, 78725 Renogram 78800-78807 Tumor imaging 5 78600-78607, 7860 Brain imaging 78579-78598 Pulmonary perfusion imaging 3 78472, 78473, 78494, 78496 Cardiac blood pool imaging / Gated Equilibrium studies 78278 GI bleed study 7820-78206 Liver scan (for Hemangioma) 78445 Vascular flow study 78457-78458 Venous thrombosis imaging 7825, 7826, 7885 Spleen imaging 78300-78320 Bone scan agent 78700-78725 Renal scan agent 4 of 7

A9567 Technetium Tc-99m Pentetate, Diagnostic, aerosol, per study dose, up to 75 mci s 78579-78598 Lung ventilation A9569 Technetium TC-99m Exametazime labeled autologous white blood cells, Diagnostic, per study dose 78805-78807 Infection detection A9570 A957 A9572 A9582 Indium- labeled autologous white blood cells, diagnostic, per study dose Indium in- labeled autologous platelets, diagnostic, per study dose Indium- Pentetreotide (OctreoScan ), Diagnostic, per study dose, up to 6 millicuries Iodine i-23 Iobenguane, diagnostic, per study dose, up to 5 millicuries AdreView ) 78805-78807, 7885 Leukocyte labeling 7890-789 Platelet labeling 78075 Adrenal imaging 7805-7808 Thyroid imaging 78800-78804 Radiopharmaceutical localization of tumor 78075 Adrenal imaging 78800-78804 Neuroblastoma imaging 5 of 7

Non-Covered Services: Code A955* A9526 Contrast agents billed in conjunction with an MRI Radiopharmaceuticals billed in conjunction with a PET scan Materials billed with a CT or other radiographic study not mentioned above Non-Ionic Contrasts or low osmolar contrast material Isotopes for therapeutic purposes are not covered under these payment rules Non-Covered Code Description Choline c-, diagnostic, per study dose up to 20 millicuries Nitrogen n-3 ammonia, diagnostic, per study dose, up to 40 millicuries A9552 Fluorodeoxyglucose f-8 fdg, diagnostic, per study dose, up to 45 millicuries A9555 Rubidium Rb-82, diagnostic, per study dose, up to 60 millicuries A9576 Injection, gadoteridol, (prohance multipack), per ml A9577 Injection, gadobenate dimeglumine (multihance), per ml A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (NOS A9580 Sodium fluoride f-8, diagnostic, per study dose, up to 30 millicuries A958 Injection, gadoxetate disodium, ml A9585 Injection, gadobutrol, 0. ml A9587* Gallium ga-68, dotatate, diagnostic, 0. millicurie A9588* Fluciclovine f-8, diagnostic, millicurie A9586 Florbetapir f8, diagnostic, per study dose, up to 0 millicuries A9597* Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not Positron th i emission l ifi d tomography radiopharmaceutical, diagnostic, for non-tumor identification, not A9598* otherwise classified A9698 Non-radioactive contrast imaging material, noc, per study A9700 Supply of injectable contrast material for use in echocardiography, per study C946 Choline C, diagnostic, per study dose Q995 Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml Q9953 Injection, iron-based magnetic resonance contrast agent Q9954 Oral magnetic resonance contrast agent, per ml Q9958 High osmolar contrast material, up to 49 mg/ml iodine concentration, per ml Q9959 High osmolar contrast material, 50-99 mg/ml iodine concentration, per ml Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml Q996 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml Q9964 High osmolar contrast material, 400 or greater mg/ml iodine concentration, per Q9965 Low osmolar contrast material, 00-99 mg/ml iodine concentration, per ml 6 of 7

Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9968 Methylene blue, isosulfan blue), mg Q9982 Flutemetamol F8, diagnostic, per study dose, up to 5 millicuries Q9983 Florbetaben f8, diagnostic, per study dose, up to 8. millicuries *Added 207 7 of 7